|Articles|January 1, 2002
PDT may aid patients with minimally classic CNV
Study of verteporfin therapy leads to new VIM Trial to determine effectof fluence rate, light dose
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Evolving glaucoma therapy: A new era of interventional strategies
2
Throwback Series: The eye that found a cancer
3
Development of maculopathy associated with systemic medications
4
Throwback Series: When tools of the past teach new lessons
5













































.png)


